Likely active: new deal Sep 2025 Verified 7 Nov 2026
Forbion
Naarden-based life sciences venture capital firm with company formation, Ventures, Growth and BioEconomy strategies that back biotech therapeutics and sustainable biotech companies.
- Type
- VC firm
- Location
- Naarden, Netherlands
- Stages
- Seed, Series A, Series B, Growth
- Sectors
- Healthtech and life sciences, Biotech, Climate and cleantech, Bioeconomy
- Fund size / AUM
- EUR 7.5bn across 13 funds (own site)
- Website
- forbion.com
Contacts on file
For Forbion, the paid file holds: 2 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
AzafarosVectorYGenomines
Sources
- forbion.com/
- forbion.com/portfolio/
- forbion.com/team/
- forbion.com/portfolio/azafaros/
- forbion.com/contact/
- nvp.nl/about-us/member-overview/members/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 30 lists
Venture capital firms in the Netherlands (47)Startup investors in the Netherlands (69)Series B biotech investors (73)Biotech investors in Europe (89)Series B climate tech investors (98)Growth-stage biotech investors (109)Series B investors in Europe (117)Series A biotech investors (153)Series B healthtech investors (160)Growth-stage climate tech investors (189)Climate tech investors in Europe (250)Series A climate tech investors (263)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Seed biotech investors (300)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Venture capital firms in Europe (412)Seed climate tech investors (458)Biotech investors (484)Seed investors in Europe (543)Climate tech investors (660)Growth-stage investors (705)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)